Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Introduction: Cases of de novo immune thrombocytopenia (ITP), including a fatality following SARS-CoV-2 vaccination in a previously healthy recipient, led to studying its impact in pre-existing ITP. Published reports are limited but suggest that most patients with ITP tolerate the COVID-19 vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun-Ju, Beltrami Moreira, Marina, Al-Samkari, Hanny, Cuker, Adam, MacWhirter - DiRaimo, Jennifer, Gernsheimer, Terry B., Kruse, Alexandra, Kessler, Craig M., Kruse, Caroline, Leavitt, Andrew D, Lee, Alfred Ian, Liebman, Howard A., Newland, Adrian C., Ray, Ashley E., Tarantino, Michael D, Thachil, Jecko, Kuter, David J., Cines, Douglas B., Bussel, James B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
311.Disorders of Platelet Number or Function: Clinical and Epidemiological
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701617/
http://dx.doi.org/10.1182/blood-2021-152918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701617/
http://dx.doi.org/10.1182/blood-2021-152918

Ejemplares similares